跳至主要内容
临床试验/DRKS00020361
DRKS00020361暂停未知

TASTE II Trial - Impact of taste and smell training and structured, individualized nutritional intervention to improve taste perception in patients receiving chemotherapy - a multicenter trial - TASTE II

Hubertus Wald Tumorzentrum - Universitäres Cancer Center HamburgUniversitäres Klinikum Hamburg- Eppendorf (UKE)0 个研究点目标入组 100 人开始时间: 2020年10月28日最近更新:
适应症

试验速览

阶段
未知
状态
暂停
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with an objective taste disorder (measured using taste strips Taste Strips) with a point score <9 points
  • - Patients with active cancer receiving outpatient chemotherapy including taxanes, platinum derivatives, athracyclines and / or antimetabolites
  • - Age <18 years
  • - existing written declaration of consent

排除标准

  • - Presence of a genetic metabolic disorder
  • - Treatment / previous treatment for an eating disorder (anorexia, bulimia, binge eating)
  • - Parenteral nutrition, enteral supplementary food (food via PEG or PEJ) or with high-calorie drinking food (if> 50% of the energy requirement is covered by drinking food) under therapy for tumor cachexia
  • - Radiation in the head and neck area
  • - pregnancy

研究者

发起方
Hubertus Wald Tumorzentrum - Universitäres Cancer Center HamburgUniversitäres Klinikum Hamburg- Eppendorf (UKE)

相似试验

TASTE II Trial - Impact of taste and smell training... | 临床试验